De Serrano and Burkhart
J Nanobiotechnol (2017) 15:83
DOI 10.1186/s12951-017-0319-9
REVIEW
Liposomal
vaccine formulations
as prophylactic agents: design considerations
for modern vaccines
Luis O. De Serrano and David J. Burkhart
*
Abstract
Vaccinology is one of the most important cornerstones in modern medicine, providing better quality of life. The
human immune system is composed of innate and adaptive immune processes that interplay when infection occurs.
Innate immunity relies on pathogen-associated molecular patterns which are recognized
by pathogen recognition
receptors localized in antigen presenting cells. After antigen processing and presentation, CD4
+
T cell polarization
occurs, further leading to B cell and CD8
+
activation and humoral and cell-mediated adaptive immune responses.
Liposomes are being employed as vaccine technologies and their design is of importance to ensure proper immune
responses. Physicochemical
parameters like liposome size, charge, lamellarity and bilayer fluidity must be completely
understood to ensure optimal vaccine stability and efficacy. Liposomal vaccines can be developed to target specific
immune cell types for the induction of certain immune responses. In this review, we will
present promising liposomal
vaccine approaches for the treatment of important viral, bacterial, fungal and parasitic infections (including tuberculo-
sis, TB). Cationic liposomes are the most studied liposome types due to their enhanced interaction
with the negatively
charged immune cells. Thus, a special section on the cationic lipid dimethyldioctadecylammonium and TB is also
presented.
Keywords: Liposomes, Vaccine formulations, CLR, TLR, Viral
infections, Bacterial infections, Parasites
© The Author(s) 2017. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License
(
http://creativecommons.org/licenses/by/4.0/
),
which permits unrestricted use, distribution, and reproduction in any medium,
provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license,
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (
http://creativecommons.org/
publicdomain/zero/1.0/
) applies to the data made available in this article, unless otherwise stated.